Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

QUERI Implementation Research Group

De-implementing inhaled corticosteroids to improve quality and safety for patients with mild-to-moderate COPD: Mixed-methods findings of primary-care providers’ perspectives


by Christian Helfrich, PhD, MPH ; Krysttel Stryczek, MA
Seminar date: 12/7/2017

Description: Inhaled corticosteroids (ICS) are widely used to treat mild to moderate chronic obstructive pulmonary disease (COPD) despite an increased risk of pneumonia and the availability of safer alternatives. As part of a quality improvement initiative to discontinue inappropriate ICS therapy, we used interviews and surveys to explore primary care providers’ experiences prescribing ICS for patients with mild to moderate COPD. In this Cyberseminar we will discuss findings about the role of multiple prescribing providers and awareness of practice guidelines, and implications for other efforts to de-prescribe ineffective or harmful therapies. Intended audience: Researchers studying de-implementation of ineffective and harmful practices and clinicians and administrators interested in patient safety.



DOWNLOAD: PDF handout | Audio only (mp3) | transcript


Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.